Holen Sie sich die Stockscreener-App
7.56
0.66%
-0.05
Handel nachbörslich:
7.56
Schlusskurs vom Vortag:
$7.61
Offen:
$7.6
24-Stunden-Volumen:
454.39K
Relative Volume:
1.48
Marktkapitalisierung:
$171.33M
Einnahmen:
$52.55M
Nettoeinkommen (Verlust:
$-23.69M
KGV:
-8.0426
EPS:
-0.94
Netto-Cashflow:
$-15.29M
1W Leistung:
-10.74%
1M Leistung:
-36.79%
6M Leistung:
+14.55%
1J Leistung:
+84.39%
1-Tages-Spanne:
$7.45
$7.645
1-Wochen-Bereich:
$7.45
$8.55
52-Wochen-Spanne:
$2.76
$12.23
Exagen Inc Stock (XGN) Company Profile
Firmenname
Exagen Inc
Sektor
Branche
Telefon
(760) 560-1501
Adresse
1261 LIBERTY WAY, VISTA, CA
Vergleichen Sie XGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
7.56 | 172.47M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Eingeleitet | B. Riley Securities | Buy |
| 2025-07-30 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-04-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cowen | Outperform |
| 2019-10-14 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Exagen Inc Aktie (XGN) Neueste Nachrichten
Why Analysts Are Updating Exagen’s Story After Higher Targets and Growth Outlook - Yahoo Finance
Is Exagen Inc. (E08A) stock a momentum leaderMarket Sentiment Summary & Safe Entry Zone Tips - newser.com
Is Exagen Inc. (E08A) stock protected from inflationWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Exagen Inc. stock split attract more investors2025 Growth vs Value & Daily Stock Trend Reports - newser.com
Is Exagen Inc. stock a contrarian buyProfit Target & Daily Oversold Stock Bounce Ideas - newser.com
Why Exagen Inc. (E08A) stock stays resilient2025 Price Momentum & Target Return Focused Stock Picks - newser.com
Is Exagen Inc. (E08A) stock good for wealth creationVolume Spike & Risk Managed Trade Strategies - newser.com
Visual trend scoring systems applied to Exagen Inc.Weekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
What to do if you’re stuck in Exagen Inc.Entry Point & Fast Moving Market Watchlists - newser.com
Short interest data insights for Exagen Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com
How supply shortages influence Exagen Inc. (E08A) stock2025 Stock Rankings & Real-Time Chart Breakout Alerts - newser.com
Can Exagen Inc. stock sustain revenue growth2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target By Investing.com - Investing.com South Africa
Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target - Investing.com India
The Market Doesn't Like What It Sees From Exagen Inc.'s (NASDAQ:XGN) Revenues Yet As Shares Tumble 27% - simplywall.st
Head-To-Head Analysis: EssilorLuxottica (OTCMKTS:ESLOY) and Exagen (NASDAQ:XGN) - Defense World
Exagen (XGN) Price Target Increased by 17.39% to 15.74 - Nasdaq
Is Exagen Inc. stock a defensive play in 2025July 2025 Summary & Reliable Volume Spike Alerts - newser.com
How higher bond yields impact Exagen Inc. (E08A) stockPortfolio Return Report & Weekly Breakout Stock Alerts - newser.com
Is Exagen Inc. stock attractive for long term wealth buildingWeekly Risk Report & Consistent Profit Alerts - newser.com
How to monitor Exagen Inc. with trend dashboardsGold Moves & High Yield Equity Trading Tips - newser.com
Exagen Inc. stock retracement – recovery analysisMarket Risk Summary & Fast Moving Market Watchlists - newser.com
Finanzdaten der Exagen Inc-Aktie (XGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.35%
1.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):